Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session of use of fifth generation cephalosporins in treating complicated skin and soft tissue infections (cSSTIs). In this webinar, the speakers, Dr. Atul Mishra and Dr. Neha Gupta has shared the important facts associated with the management of cSSTIs.
Antibiotic resistance is the most common threat that the infectious diseases specialists need to deal with. The emergence of different multi antibiotic resistant infectious strains are threatening the treatment approaches.
Complicated skin and soft tissue infections (cSSTIs) typically involve deep soft tissues. It is mostly observed in patients with underlying disease and it often requires intravenous antibiotic therapy, surgical intervention, or both. The situation of cSSTIs becomes worse when it is accompanied by MRSA infection.
Fifth generation cephalosporin, Ceftobiprole. possesses anti-pseudomonal activity and appears to be less susceptible to development of resistance. Further, it can also treat infections that are resistant to other antibiotics, including MRSA infections.
Therefore, have an overall knowledge on cSSTIs management using fifth generation cephalosporin from different case presentations. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Survival rates for incurable larynx cancer investigated for first time
2.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
3.
Knowing about and avoiding bladder cancer.
4.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
5.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
1.
Evidence-Based Approaches in Hematology for Modern Medicine
2.
Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery
3.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
4.
The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation